We are Aidence: we rally the brightest minds to drastically improve medical diagnostics using AI
Our team consists of data science, medical and regulatory experts, supported by a talented team of professionals, experienced advisors, and critical users.
Together we built Veye Lung Nodules and Veye Reporting, our first AI clinical applications for early lung cancer diagnosis and reporting.
Mission
We provide intelligent software that empowers healthcare and pharmaceutical professionals to deliver faster, more precise diagnostics and treatments.
Vision
Data is key to improve the prevention, management, and treatment of diseases.
Partners
Roadmap
Future Roadmap
Expand the suite of chest applications to tumours and coronary artery calcification.
Augment oncology pathways with solutions for patient follow-up and multidisciplinary team meetings (MDTs).
Awards
Winner,
AI in Health and Care Award Phase 4 (2020)
Finalist,
UCSF Digital Health Awards, “Best digital health product or service for enabling better mental & behavioral health and wellness” (2019)
Third place,
Kaggle DataScience Bowl “Can you improve lung cancer detection?” (2017)
Values
Human sense.
Our purpose is to improve people’s lives, from caregiver to patient.
Humility.
We’re in a hyped industry, but we never exaggerate our capabilities.
Accountability.
We deliver what we promise, on time.
Transparency.
We encourage all stakeholders to speak openly and share their ideas.
Perseverance.
We perfect one product before building the next and never stop improving.
Aidence is a daughter company of RadNet
